Travere Therapeutics (TVTX) Income from Continuing Operations (2011 - 2026)
Travere Therapeutics posted quarterly Income from Continuing Operations of 36602000.0 for Q1 2026, up 11.22% year-on-year from 32910666.35 in Q1 2025, and down 66.48% on a QoQ basis from 21986000.0 in Q4 2025.
Travere Therapeutics (TVTX) has 16 years of Income from Continuing Operations data on file, last reported at 36602000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations rose 11.22% year-over-year to 36602000.0; the trailing twelve-month figure through Mar 2026 stood at 45637000.0 (up 79.8% YoY), and the FY2025 full-year result was 50261000.0, up 84.32% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 36602000.0, down from 21986000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 25706000.0 in Q3 2025 and bottomed at 135958000.0 in Q1 2024.
- The 5-year median for Income from Continuing Operations is 80023000.0 (2022), against an average of 65605529.41.
- The widest annual swing landed in 2022, when Income from Continuing Operations sank 135.87%; it then jumped 146.95% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 85636000.0 in 2022, then slipped by 3.46% to 88596000.0 in 2023, then soared by 31.97% to 60268000.0 in 2024, then soared by 63.52% to 21986000.0 in 2025, then tumbled by 66.48% to 36602000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 36602000.0 (Q1 2026), 21986000.0 (Q4 2025), and 25706000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -8.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.40 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Travere Therapeutics | 4.14 Bn | 4.06 Bn | 102.38 Mn | -36.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.60 Mn |
| Dec 31, 2025 | -21.99 Mn |
| Sep 30, 2025 | 25.71 Mn |
| Jun 30, 2025 | -12.76 Mn |
| Mar 31, 2025 | -41.23 Mn |
| Dec 31, 2024 | -60.27 Mn |
| Sep 30, 2024 | -54.75 Mn |
| Jun 30, 2024 | -69.65 Mn |
| Mar 31, 2024 | -135.96 Mn |
| Dec 31, 2023 | -88.60 Mn |
| Sep 30, 2023 | -89.24 Mn |
| Jun 30, 2023 | -101.93 Mn |
| Mar 31, 2023 | -96.56 Mn |
| Dec 31, 2022 | -85.64 Mn |
| Sep 30, 2022 | -84.06 Mn |
| Jun 30, 2022 | -80.02 Mn |
| Mar 31, 2022 | -81.75 Mn |
| Dec 31, 2021 | -88.77 Mn |
| Sep 30, 2021 | -35.64 Mn |
| Jun 30, 2021 | -39.01 Mn |
| Mar 31, 2021 | -53.85 Mn |
| Dec 31, 2020 | -121.62 Mn |
| Sep 30, 2020 | -22.55 Mn |
| Jun 30, 2020 | -26.07 Mn |
| Mar 31, 2020 | 808,000.00 |
| Dec 31, 2019 | -30.26 Mn |
| Sep 30, 2019 | -36.49 Mn |
| Jun 30, 2019 | -38.70 Mn |
| Mar 31, 2019 | -40.98 Mn |
| Dec 31, 2018 | -7.46 Mn |
| Sep 30, 2018 | -54.52 Mn |
| Jun 30, 2018 | -22.33 Mn |
| Mar 31, 2018 | -18.38 Mn |
| Dec 31, 2017 | -17.62 Mn |
| Sep 30, 2017 | -17.79 Mn |
| Jun 30, 2017 | -13.23 Mn |
| Mar 31, 2017 | -11.09 Mn |
| Dec 31, 2016 | -8.60 Mn |
| Sep 30, 2016 | -37.11 Mn |
| Jun 30, 2016 | -13.40 Mn |
| Mar 31, 2016 | 11.22 Mn |
| Dec 31, 2015 | -2.47 Mn |
| Sep 30, 2015 | 105.58 Mn |
| Jun 30, 2015 | -25.53 Mn |
| Mar 31, 2015 | 39.66 Mn |
| Dec 31, 2014 | -29.03 Mn |
| Sep 30, 2014 | -17.98 Mn |
| Jun 30, 2014 | 11.81 Mn |
| Mar 31, 2014 | -75.74 Mn |
| Dec 31, 2013 | -12.75 Mn |
| Sep 30, 2013 | -12.01 Mn |
| Jun 30, 2013 | -4.92 Mn |
| Mar 31, 2013 | -4.87 Mn |
| Aug 31, 2012 | -3,500.00 |
| May 31, 2012 | -3,509.00 |
| Aug 31, 2011 | -3,525.00 |